Literature DB >> 17117013

Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.

Priscilla Y Hsue1, Peter W Hunt, Elizabeth Sinclair, Barry Bredt, Arlana Franklin, Maudi Killian, Rebecca Hoh, Jeffrey N Martin, Joseph M McCune, David D Waters, Steven G Deeks.   

Abstract

OBJECTIVES: HIV-infected subjects are at increased risk for myocardial infarction. The mechanism of this increased risk remains unclear. Since cytomegalovirus (CMV) infection has been associated with accelerated atherosclerosis in the transplant population and immune responses against CMV may be altered by HIV disease, we hypothesized that enhanced T-cell responses against CMV would be associated with increased atherosclerosis in subjects with HIV.
METHODS: We measured high-sensitivity C-reactive protein (hs-CRP), T-cell activation, CMV-specific T-cell responses, and carotid artery intima-media thickness (IMT) in 93 HIV-infected subjects and in 37 uninfected controls.
RESULTS: The mean age of the HIV-infected subjects was 48 years and 85 (91%) were male. The median carotid IMT was higher in the HIV-infected group compared to the uninfected group (0.95 mm versus 0.68 mm, P < 0.001). This difference remained significant after controlling for all traditional risk factors. Compared to HIV-negative controls, HIV-infected subjects had higher median levels of hs-CRP (P = 0.05), higher levels of CD4 and CD8 T-cell activation (P < 0.0001) and higher CMV-specific interferon-gamma CD8 T-cell responses (P < 0.0001). CMV-specific T-cell responses, but not hs-CRP and T-cell activation, were independently associated with higher carotid IMT (P = 0.001).
CONCLUSIONS: HIV-infected subjects had thicker carotid IMT compared to controls. While HIV patients also had higher T-cell activation, hs-CRP levels, and CMV-specific T-cell responses, only CMV-specific T-cell responses were independently associated with IMT. Accelerated atherosclerosis in HIV patients may be mediated by heightened CMV-induced immune responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117013     DOI: 10.1097/QAD.0b013e3280108704

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  131 in total

Review 1.  HIV and inflammation: mechanisms and consequences.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2012-06       Impact factor: 5.071

Review 2.  HIV infection and immune activation: the role of coinfections.

Authors:  Afroditi Boulougoura; Irini Sereti
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

Review 3.  Infection and Stroke: an Update on Recent Progress.

Authors:  Eliza C Miller; Mitchell S V Elkind
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 4.  Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.

Authors:  Michael L Freeman; Michael M Lederman; Sara Gianella
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

5.  CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.

Authors:  Michael L Freeman; Joseph C Mudd; Carey L Shive; Souheil-Antoine Younes; Soumya Panigrahi; Scott F Sieg; Sulggi A Lee; Peter W Hunt; Leonard H Calabrese; Sara Gianella; Benigno Rodriguez; Michael M Lederman
Journal:  Clin Infect Dis       Date:  2015-09-23       Impact factor: 9.079

6.  A role for cytomegalovirus-specific CD4+CX3CR1+ T cells and cytomegalovirus-induced T-cell immunopathology in HIV-associated atherosclerosis.

Authors:  Karim Sacre; Peter W Hunt; Priscilla Y Hsue; Ekaterina Maidji; Jeffrey N Martin; Steven G Deeks; Brigitte Autran; Joseph M McCune
Journal:  AIDS       Date:  2012-04-24       Impact factor: 4.177

7.  Persistent immune activation in chronic HIV infection: do any interventions work?

Authors:  Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin
Journal:  AIDS       Date:  2013-05-15       Impact factor: 4.177

Review 8.  Cardiovascular complications in HIV management: past, present, and future.

Authors:  Judith A Aberg
Journal:  J Acquir Immune Defic Syndr       Date:  2009-01-01       Impact factor: 3.731

Review 9.  Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.

Authors:  Babafemi Taiwo; Luis Barcena; Randall Tressler
Journal:  Curr HIV/AIDS Rep       Date:  2013-03       Impact factor: 5.071

10.  Inflammation and Fibrosis in HIV: Getting to the Heart of the Matter.

Authors:  Priscilla Y Hsue; Ahmed Tawakol
Journal:  Circ Cardiovasc Imaging       Date:  2016-03       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.